Literature DB >> 7518437

Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion.

X B Chang1, Y X Hou, T J Jensen, J R Riordan.   

Abstract

Technical difficulties in obtaining three-dimensional structures of intrinsic membrane proteins continues to limit understanding of their function. However, considerable insight can be gained from their two-dimensional topological arrangement in the lipid bilayer. Efficient molecular genetic approaches are available to discern the topology of prokaryotic but not of eukaryotic membrane proteins. The absolute asymmetry of the sidedness of their N-glycosylation was employed here to develop such a method using the cystic fibrosis transmembrane conductance regulator (CFTR). Insertion by in vitro mutagenesis of N-glycosylation consensus sequences (NXS/T) in predicted cytoplasmic and extracytoplasmic loops between hydrophobic sequences capable of traversing the membrane established the membrane topology of CFTR. This provides the first experimental evaluation of the original topological model of CFTR based solely on hydropathy algorithms and a method which may be generally applicable for the in vivo evaluation of the topology of other mammalian membrane proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518437

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Topology studies with biosynthetic fragments identify interacting transmembrane regions of the human red-cell anion exchanger (band 3; AE1).

Authors:  J D Groves; M J Tanner
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

Review 2.  Membrane topology and insertion of membrane proteins: search for topogenic signals.

Authors:  M van Geest; J S Lolkema
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide.

Authors:  M M Hämmerle; A A Aleksandrov; X B Chang; J R Riordan
Journal:  Glycoconj J       Date:  2000-11       Impact factor: 2.916

4.  Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator.

Authors:  X Xiong; A Bragin; J H Widdicombe; J Cohn; W R Skach
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

5.  Transmembrane topology of a CLC chloride channel.

Authors:  T Schmidt-Rose; T J Jentsch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

6.  Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures.

Authors:  Deborah M Cholon; Wanda K O'Neal; Scott H Randell; John R Riordan; Martina Gentzsch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-11       Impact factor: 5.464

7.  Structural analysis of cloned plasma membrane proteins by freeze-fracture electron microscopy.

Authors:  S Eskandari; E M Wright; M Kreman; D M Starace; G A Zampighi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

8.  Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome.

Authors:  M A Loo; T J Jensen; L Cui; Y Hou; X B Chang; J R Riordan
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

9.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

10.  Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Martina Gentzsch; Xiu-Bao Chang; Liying Cui; Yufeng Wu; Victor V Ozols; Amit Choudhury; Richard E Pagano; John R Riordan
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.